Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-06-005266
Filing Date
2006-03-16
Accepted
2006-03-16 11:40:08
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d33964e10vk.htm 10-K 912269
2 ORAL HEALTHCARE ALLIANCE AGREEMENT d33964exv10w53.htm EX-10.53 109423
3 COMMON STOCK PURCHASE AGREEMENT d33964exv10w54.htm EX-10.54 98438
4 LIST OF SUBSIDIARIES d33964exv21w1.htm EX-21.1 2196
5 COSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d33964exv23w1.htm EX-23.1 1568
6 CERTIFICATION OF CEO & CFO PURSUANT TO RULE 13A-(A) d33964exv31w1.htm EX-31.1 14244
7 CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 d33964exv32w1.htm EX-32.1 4021
  Complete submission text file 0000950134-06-005266.txt   1143550
Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Filer) CIK: 0001018710 (see all company filings)

EIN.: 742704230 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21291 | Film No.: 06690580
SIC: 2834 Pharmaceutical Preparations